Thursday's Biggest Gainers
AsiaInfo Holdings (NASDAQ:ASIA - News) shares gained after the Beijing-based software company said it has recently signed contracts to upgrade the business support systems of China Telecom's Henan, Shanxi, Tianjin and Heilongjiang subsidiaries. Financial terms of the contracts were not disclosed.
Champion Industries Inc. (NASDAQ:CHMP - News) reported fiscal fourth-quarter earnings more than tripled to 20 cents a share from 6 cents in the year-earlier period. Revenue in the three months ended Oct. 31 rose 6.6% to $37 million.
First Cash Financial Services Inc. (NASDAQ:FCFS - News) will replace Republic Bancorp Inc. (NASDAQ:RBNC - News) in the Standard & Poor's SmallCap 600 index after trading closes on Friday. Citizens Banking Corp. (NASDAQ:CBCF - News) is acquiring Republic in a deal expected to close on or about that date.
Openwave Systems (NASDAQ:OPWV - News) shares advanced after Harbinger Capital Partners announced late Wednesday it plans to nominate two directors, James Zucco and Andrew Breen, to the Redwood City, Calif.-based software company's board. The company's shareholders will vote on the nominees at Openwave's annual meeting on Jan. 17. Harbinger said Zucco and Breen, if elected, would recommend phasing-out non-performing product lines, reducing quarterly operating expenses to roughly $50 million and launching a "significant" share repurchase program.
Rick's Cabaret International (NASDAQ:RICK - News) shares surged after the Houston-based company reported fiscal 2006 net earnings of $1.75 million, or 35 cents a share. In fiscal 2005, the nightclub operator posted a net loss of $215,148, or 5 cents a share. Revenue in the year ended Sept. 30 rose to $24.5 million from $14.8 million. "Our growth program is on track and we are looking forward to another strong year in 2007 from our existing clubs and the four acquisitions we have made recently," said Eric Langan, president and chief executive, in a statement. "We will also continue to look at additional acquisitions that fit our business model and can be quickly accretive."
SciClone Pharmaceuticals Inc. (NASDAQ:SCLN - News)and its European partner, Sigma-Tau, said they've completed patient enrollment for the Phase III clinical trial evaluating Zadaxin in combination with pegylated interferon alpha and ribavirin to treat patients with the hepatitis C virus. The trial is being conducted by Sigma-Tau in Europe and has enrolled 553 patients.
By MarketWatch
Champion Industries Inc. (NASDAQ:CHMP - News) reported fiscal fourth-quarter earnings more than tripled to 20 cents a share from 6 cents in the year-earlier period. Revenue in the three months ended Oct. 31 rose 6.6% to $37 million.
First Cash Financial Services Inc. (NASDAQ:FCFS - News) will replace Republic Bancorp Inc. (NASDAQ:RBNC - News) in the Standard & Poor's SmallCap 600 index after trading closes on Friday. Citizens Banking Corp. (NASDAQ:CBCF - News) is acquiring Republic in a deal expected to close on or about that date.
Openwave Systems (NASDAQ:OPWV - News) shares advanced after Harbinger Capital Partners announced late Wednesday it plans to nominate two directors, James Zucco and Andrew Breen, to the Redwood City, Calif.-based software company's board. The company's shareholders will vote on the nominees at Openwave's annual meeting on Jan. 17. Harbinger said Zucco and Breen, if elected, would recommend phasing-out non-performing product lines, reducing quarterly operating expenses to roughly $50 million and launching a "significant" share repurchase program.
Rick's Cabaret International (NASDAQ:RICK - News) shares surged after the Houston-based company reported fiscal 2006 net earnings of $1.75 million, or 35 cents a share. In fiscal 2005, the nightclub operator posted a net loss of $215,148, or 5 cents a share. Revenue in the year ended Sept. 30 rose to $24.5 million from $14.8 million. "Our growth program is on track and we are looking forward to another strong year in 2007 from our existing clubs and the four acquisitions we have made recently," said Eric Langan, president and chief executive, in a statement. "We will also continue to look at additional acquisitions that fit our business model and can be quickly accretive."
SciClone Pharmaceuticals Inc. (NASDAQ:SCLN - News)and its European partner, Sigma-Tau, said they've completed patient enrollment for the Phase III clinical trial evaluating Zadaxin in combination with pegylated interferon alpha and ribavirin to treat patients with the hepatitis C virus. The trial is being conducted by Sigma-Tau in Europe and has enrolled 553 patients.
By MarketWatch
posted by Stock Administrator @ 11:42 AM
0 Comments:
Post a Comment
<< Home